44 related articles for article (PubMed ID: 19239365)
1. Predicting the response to combination antiretroviral therapy: retrospective validation of geno2pheno-THEO on a large clinical database.
Altmann A; Däumer M; Beerenwinkel N; Peres Y; Schülter E; Büch J; Rhee SY; Sönnerborg A; Fessel WJ; Shafer RW; Zazzi M; Kaiser R; Lengauer T
J Infect Dis; 2009 Apr; 199(7):999-1006. PubMed ID: 19239365
[TBL] [Abstract][Full Text] [Related]
2. Machine Learning to Improve the Effectiveness of ANRS in Predicting HIV Drug Resistance.
Singh Y
Healthc Inform Res; 2017 Oct; 23(4):271-276. PubMed ID: 29181236
[TBL] [Abstract][Full Text] [Related]
3. Machine Learning Classification of False-Positive Human Immunodeficiency Virus Screening Results.
Elkhadrawi M; Stevens BA; Wheeler BJ; Akcakaya M; Wheeler S
J Pathol Inform; 2021; 12():46. PubMed ID: 34934521
[TBL] [Abstract][Full Text] [Related]
4. A Bayesian nonparametric approach for inferring drug combination effects on mental health in people with HIV.
Jin W; Ni Y; Rubin LH; Spence AB; Xu Y
Biometrics; 2022 Sep; 78(3):988-1000. PubMed ID: 34145900
[TBL] [Abstract][Full Text] [Related]
5. Human Immunodeficiency Virus Drug Resistance: 2018 Recommendations of the International Antiviral Society-USA Panel.
Günthard HF; Calvez V; Paredes R; Pillay D; Shafer RW; Wensing AM; Jacobsen DM; Richman DD
Clin Infect Dis; 2019 Jan; 68(2):177-187. PubMed ID: 30052811
[TBL] [Abstract][Full Text] [Related]
6. Collaborative update of a rule-based expert system for HIV-1 genotypic resistance test interpretation.
Paredes R; Tzou PL; van Zyl G; Barrow G; Camacho R; Carmona S; Grant PM; Gupta RK; Hamers RL; Harrigan PR; Jordan MR; Kantor R; Katzenstein DA; Kuritzkes DR; Maldarelli F; Otelea D; Wallis CL; Schapiro JM; Shafer RW
PLoS One; 2017; 12(7):e0181357. PubMed ID: 28753637
[TBL] [Abstract][Full Text] [Related]
7. Human Retrovirus Codon Usage from tRNA Point of View: Therapeutic Insights.
Frias D; Monteiro-Cunha JP; Mota-Miranda AC; Fonseca VS; de Oliveira T; Galvao-Castro B; Alcantara LC
Bioinform Biol Insights; 2013; 7():335-45. PubMed ID: 24151425
[TBL] [Abstract][Full Text] [Related]
8. Predictions of CD4 lymphocytes' count in HIV patients from complete blood count.
Rodríguez JO; Prieto SE; Correa C; Pérez CE; Mora JT; Bravo J; Soracipa Y; Alvarez LF
BMC Med Phys; 2013 Sep; 13(1):3. PubMed ID: 24034560
[TBL] [Abstract][Full Text] [Related]
9. The individualized genetic barrier predicts treatment response in a large cohort of HIV-1 infected patients.
Beerenwinkel N; Montazeri H; Schuhmacher H; Knupfer P; von Wyl V; Furrer H; Battegay M; Hirschel B; Cavassini M; Vernazza P; Bernasconi E; Yerly S; Böni J; Klimkait T; Cellerai C; Günthard HF;
PLoS Comput Biol; 2013; 9(8):e1003203. PubMed ID: 24009493
[TBL] [Abstract][Full Text] [Related]
10. Clinical evaluation of Rega 8: an updated genotypic interpretation system that significantly predicts HIV-therapy response.
Vercauteren J; Beheydt G; Prosperi M; Libin P; Imbrechts S; Camacho R; Clotet B; De Luca A; Grossman Z; Kaiser R; Sönnerborg A; Torti C; Van Wijngaerden E; Schmit JC; Zazzi M; Geretti AM; Vandamme AM; Van Laethem K
PLoS One; 2013; 8(4):e61436. PubMed ID: 23613852
[TBL] [Abstract][Full Text] [Related]
11. HIV Drug-Resistant Patient Information Management, Analysis, and Interpretation.
Singh Y; Mars M
JMIR Res Protoc; 2012 Jun; 1(1):e3. PubMed ID: 23611761
[TBL] [Abstract][Full Text] [Related]
12. Significantly improved HIV inhibitor efficacy prediction employing proteochemometric models generated from antivirogram data.
van Westen GJ; Hendriks A; Wegner JK; Ijzerman AP; van Vlijmen HW; Bender A
PLoS Comput Biol; 2013; 9(2):e1002899. PubMed ID: 23436985
[TBL] [Abstract][Full Text] [Related]
13. Somatic mutation patterns and compound response in cancers.
He N; Kim N; Yoon S
BMB Rep; 2013 Feb; 46(2):97-102. PubMed ID: 23433112
[TBL] [Abstract][Full Text] [Related]
14. Managing drug resistance in cancer: lessons from HIV therapy.
Bock C; Lengauer T
Nat Rev Cancer; 2012 Jun; 12(7):494-501. PubMed ID: 22673150
[TBL] [Abstract][Full Text] [Related]
15. Standardized representation, visualization and searchable repository of antiretroviral treatment-change episodes.
Rhee SY; Blanco JL; Liu TF; Pere I; Kaiser R; Zazzi M; Incardona F; Towner W; Gatell JM; De Luca A; Fessel WJ; Shafer RW
AIDS Res Ther; 2012 May; 9(1):13. PubMed ID: 22554313
[TBL] [Abstract][Full Text] [Related]
16. A multifaceted analysis of HIV-1 protease multidrug resistance phenotypes.
Doherty KM; Nakka P; King BM; Rhee SY; Holmes SP; Shafer RW; Radhakrishnan ML
BMC Bioinformatics; 2011 Dec; 12():477. PubMed ID: 22172090
[TBL] [Abstract][Full Text] [Related]
17. Which compound to select in lead optimization? Prospectively validated proteochemometric models guide preclinical development.
van Westen GJ; Wegner JK; Geluykens P; Kwanten L; Vereycken I; Peeters A; Ijzerman AP; van Vlijmen HW; Bender A
PLoS One; 2011; 6(11):e27518. PubMed ID: 22132107
[TBL] [Abstract][Full Text] [Related]
18. A prognostic model for estimating the time to virologic failure in HIV-1 infected patients undergoing a new combination antiretroviral therapy regimen.
Prosperi MC; Di Giambenedetto S; Fanti I; Meini G; Bruzzone B; Callegaro A; Penco G; Bagnarelli P; Micheli V; Paolini E; Di Biagio A; Ghisetti V; Di Pietro M; Zazzi M; De Luca A;
BMC Med Inform Decis Mak; 2011 Jun; 11():40. PubMed ID: 21672248
[TBL] [Abstract][Full Text] [Related]
19. Proteochemometric modeling of the susceptibility of mutated variants of the HIV-1 virus to reverse transcriptase inhibitors.
Junaid M; Lapins M; Eklund M; Spjuth O; Wikberg JE
PLoS One; 2010 Dec; 5(12):e14353. PubMed ID: 21179544
[TBL] [Abstract][Full Text] [Related]
20. Models of RNA virus evolution and their roles in vaccine design.
Ojosnegros S; Beerenwinkel N
Immunome Res; 2010 Nov; 6 Suppl 2(Suppl 2):S5. PubMed ID: 21067547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
